Efficacy and safety of natalizumab in children with highly active relapsing-remitting multiple sclerosis

被引：0
|
作者：
Karageorgiou, Klimentini E. [1 ]
Polyzoi, Maria [1 ]
Tzitzika, Moira [1 ]
Xatzi, Ioanna [1 ]
Alexoudi, Athanasia [1 ]
机构：
[1] Athens Gen Hosp G Gennimatas, Athens, Greece
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of natalizumab as escalation therapy in relapsing-remitting multiple sclerosis
    Putzki, Norman
    Kiriaki, Kollia
    Katsarava, Zaza
    Woods, Sophia
    Give, Ezinne
    Diener, H.
    [J]. NEUROLOGY, 2008, 70 (11) : A90 - A90
  • [2] Subcutaneously delivered natalizumab for the treatment of highly active relapsing-remitting multiple sclerosis
    Haluskova, S.
    Valis, M.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (03) : 206 - 212
  • [3] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [4] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    [J]. NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [5] Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
    Kalincik, T.
    Horakova, D.
    Spelman, T.
    Jokubaitis, V.
    Trojano, M.
    Lugaresi, A.
    Izquierdo, G.
    Rozsa, C.
    Grammond, P.
    Alroughani, R.
    Duquette, P.
    Girard, M.
    Pucci, E.
    Lechner-Scott, J.
    Slee, M.
    Fernandez-Bolanos, R.
    Grand'Maison, F.
    Hupperts, R.
    Verheul, F.
    Hodgkinson, S.
    Oreja-Guevara, C.
    Spitaleri, D.
    Barnett, M.
    Terzi, M.
    Bergamaschi, R.
    McCombe, P.
    Sanchez-Menoyo, J.
    Simo, M.
    Csepany, T.
    Rum, G.
    Boz, C.
    Havrdova, E.
    Butzkueven, H.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 195 - 196
  • [6] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
    Rodriguez de Castro, Belen
    Martinez-Mugica Barbosa, Cristina
    Ayastuy Ruiz, Aitor
    Fernandez Gonzalez, Beatriz
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
  • [7] Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis
    Derfuss, T.
    Bergvall, N. K.
    Sfikas, N.
    Tomic, D. L.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) : 1687 - 1691
  • [8] Efficacy and safety of natalizumab in relapsing-remitting multiple sclerosis: an Italian multicentre observational study
    Bucello, S.
    Sangalli, F.
    Moiola, L.
    Annovazzi, P.
    Rizzo, A.
    Radaelli, M.
    Ghezzi, A.
    Grimaldi, L.
    Martinelli, V.
    Comi, G.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S129 - S130
  • [9] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 : S303 - S303
  • [10] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
12345